Ray continued, “We’re also delighted to acknowledge Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology were being instrumental to shaping the development of STK-012, our initially-in-course alpha/beta biased IL-two. Its special system expands the therapeutic index